Review
doi: 10.1007/978-3-642-84138-5_9.
Controlling emesis in patients receiving cancer chemotherapy
Affiliations
- PMID: 1857886
- DOI: 10.1007/978-3-642-84138-5_9
Item in Clipboard
Review
Controlling emesis in patients receiving cancer chemotherapy
Recent Results Cancer Res.
1991.
No abstract available
Similar articles
-
Preventing chemotherapy-induced nausea and vomiting: an update and a review of emesis.Semin Oncol. 1995 Aug;22(4 Suppl 10):6-18. Semin Oncol. 1995. PMID: 7570053 Review. No abstract available.
-
Controlling emesis in patients receiving cancer chemotherapy.Recent Results Cancer Res. 1988;108:89-101. doi: 10.1007/978-3-642-82932-1_12. Recent Results Cancer Res. 1988. PMID: 3051215 Review. No abstract available.
-
[Chemotherapy induced-vomiting--a practical guide for prevention and therapy].Dtsch Med Wochenschr. 2006 Aug 25;131(34-35):1869-72. doi: 10.1055/s-2006-949172. Dtsch Med Wochenschr. 2006. PMID: 16915549 Review. German.
-
An overview of chemotherapy-induced emesis highlighting the role of lorazepam as adjuvant therapy.Int J Palliat Nurs. 2002 Jul;8(7):331-5. doi: 10.12968/ijpn.2002.8.7.10673. Int J Palliat Nurs. 2002. PMID: 12165717 Review.
-
[Prevention of emesis accompanying antitumor chemotherapy].Przegl Lek. 1994;51(1):49-52. Przegl Lek. 1994. PMID: 8208995 Review. Polish. No abstract available.
Cited by
-
Efficacy of palonosetron (PAL) compared to other serotonin inhibitors (5-HT3R) in preventing chemotherapy-induced nausea and vomiting (CINV) in patients receiving moderately or highly emetogenic (MoHE) treatment: systematic review and meta-analysis.Support Care Cancer. 2011 Jun;19(6):823-32. doi: 10.1007/s00520-010-0908-8. Epub 2010 May 22. Support Care Cancer. 2011. PMID: 20495832
-
Antiemetic activity of megestrol acetate in patients receiving chemotherapy.Support Care Cancer. 2011 May;19(5):667-73. doi: 10.1007/s00520-010-0886-x. Epub 2010 Apr 26. Support Care Cancer. 2011. PMID: 20419494 Clinical Trial.